Intracranial (i.c.) lymphocytic choriomeningitis virus (LCMV) infection of mice results in T cell-driven anorexia and weight loss, which is diminished in males compared to females. We investigated sex-specific effects on antigen-presenting cells (APCs) and T cells after i.c. LCMV infection. Numbers of LCMV-specific T cells, APC activation, and levels of inflammatory cytokines and chemokines in CSF were decreased in males compared to females. Orchidectomy enhanced these immune parameters in males, while dihydrotestosterone treatment of orchidectomized males and intact females decreased some of these parameters. These data suggest that qualitative and quantitative effects of androgens on APCs and T cells may contribute to the wellknown, but poorly understood sex differences in immunity and autoimmunity.
Introduction
Sex differences are apparent in susceptibility to both infection and autoimmune disease. For example, males are more susceptible to many bacterial, viral, fungal, and parasitic infections (Klein, 2000; Offner et al., 1999) . In contrast, females are more susceptible to autoimmune diseases such as systemic lupus erythematosus (SLE), Graves' disease, rheumatoid arthritis, and multiple sclerosis (MS), among others (Ansar Ahmed et al., 1986; Cutolo et al., 2004; Olsen and Kovacs, 1996; Whitacre, 2001) . These sex differences are also observed in animal models of infection and autoimmune diseases (Ansar Ahmed et al., 1986; Harbuz et al., 1995; Klein, 2000; Roubinian et al., 1978; Voskuhl et al., 1996) . Overall, this suggests that the activity of the immune system is more robust in females compared to males. Estrogens may contribute enhanced immune responses in females, as estrogens have been shown to enhance antibodymediated responses to exogenous antigens (Brick et al., 1985) , T cell cytotoxicity (Hu et al., 1988; Muller et al., 1995; Yang et al., 2006) , cytokine and chemokine levels (Hu et al., 1988; Yang et al., 2006) , and APC activation (Hu et al., 1988; Weinstein et al., 1984) . However, estrogens have also been shown to dampen the immune response in various in vitro and in vivo models, at both physiologic and supraphysiologic levels (Barreto et al., 2007; Bebo et al., 2001; Dimayuga et al., 2005; Ito et al., 2001) . Thus, given the context, estrogens can have stimulatory or inhibitory effects on immune responses.
Conversely, substantial evidence in autoimmune models suggests that immune-suppressing effects of androgens underlie the observed sex differences in immunity. For example, removal of endogenous androgens from male mice via orchidectomy resulted in increased severity of experimental autoimmune encephalitis (EAE) (Bebo et al., 1998) , arthritis (Harbuz et al., 1995) , and autoimmune thyroiditis (Ansar Ahmed et al., 1986) . Exogenous androgen administration was protective in EAE and other immune models (Ansar Ahmed et al., 1986; Fox, 1992; Harbuz et al., 1995; Palaszynski et al., 2004) . Androgens have also been shown to decrease MHC II expression on APCs (Barreto et al., 2007; Matejuk et al., 2005) , decrease T cell proliferation (Jacobson and Ansari, 2004; Matejuk et al., 2005) , and alter the cytokine profile of activated T cells to decrease inflammation (Dalal et al., 1997; Liva and Voskuhl, 2001) , possibly via the molecule PPARα (Dunn et al., 2007) . Thus, in autoimmune models, it is clear that androgens dampen the immune response. However, in infectious models, relatively few studies have examined the effects of androgens on numbers of antigen-specific T cells and in vivo cytokine/chemokine production.
Sex differences have been reported in a well-studied mouse model of infection with lymphocytic choriomeningitis virus (LCMV) (Hildeman and Muller, 2000; Muller et al., 1995) . Intracranial (i.c.) infection of wild-type mice with LCMV results in meningitis and death, mediated by CD8+ T cells, while infection of β 2 -microglobulindeficient mice (β 2 m −/− mice) results in persistent infection with virus, meningitis, the production of pro-inflammatory cytokines, and profound anorexia and weight loss mediated by MHC class II- 
